Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bocchia

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Haematologica|November 1, 1992
Hodgkin's disease: summary of twenty years' experienceP Mazza, M Bocchia, P L Zinzani, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Leukemia & Lymphoma|February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomasP Mazza, P L Zinzani, M Martelli, et al.
Leukemia|November 11, 2005
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemiaM Bocchia, E Abruzzese, F Forconi, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.
Leukemia|May 1, 1997
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year surveyF Lauria, D Rondelli, P L Zinzani, et al.
Lancet (London, England)|February 22, 2005
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trialM Bocchia, S Gentili, E Abruzzese, et al.
Haematologica|November 14, 2000
Antitumor vaccination: where we standM Bocchia, V Bronte, M P Colombo, et al.
Haematologica|February 27, 2001
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapyP L Zinzani, M Martelli, M Bendandi, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Haematologica|November 1, 1992
Hodgkin's disease: summary of twenty years' experienceP Mazza, M Bocchia, P L Zinzani, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Leukemia & Lymphoma|February 1, 1995
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomasP Mazza, P L Zinzani, M Martelli, et al.
Leukemia|November 11, 2005
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemiaM Bocchia, E Abruzzese, F Forconi, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.
Leukemia|May 1, 1997
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year surveyF Lauria, D Rondelli, P L Zinzani, et al.
Lancet (London, England)|February 22, 2005
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trialM Bocchia, S Gentili, E Abruzzese, et al.
Haematologica|November 14, 2000
Antitumor vaccination: where we standM Bocchia, V Bronte, M P Colombo, et al.
Haematologica|February 27, 2001
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapyP L Zinzani, M Martelli, M Bendandi, et al.
Pageof 7